BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6277236)

  • 1. Nerve stimulation test in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Ann Neurol; 1982 Jan; 11(1):48-52. PubMed ID: 6277236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Bungarotoxin sensitization in experimental autoimmune myasthenia gravis.
    Kennel PF; Poindron P; Warter JM; Fonteneau P
    Muscle Nerve; 1993 May; 16(5):461-5. PubMed ID: 8390605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-fiber electromyography in experimental autoimmune myasthenia gravis.
    Verschuuren JJ; Spaans F; De Baets MH
    Muscle Nerve; 1990 Jun; 13(6):485-92. PubMed ID: 2366822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive nerve stimulation vs. twitch tension in rats with EAMG.
    Thompson PA; Barohn RA; Krolick KA
    Muscle Nerve; 1992 Jan; 15(1):94-100. PubMed ID: 1732768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological studies of acetylcholine receptors.
    Lindstrom J
    J Supramol Struct; 1976; 4(3):389-403. PubMed ID: 817087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bai XF; van der Meide PH; Orn A; Link H
    J Immunol; 1999 Apr; 162(7):3775-81. PubMed ID: 10201893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation of clinical disease to antibody titre, proliferative response and neurophysiology in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1983 Mar; 51(3):543-50. PubMed ID: 6851245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic modulation of junctional acetylcholine receptor is not sufficient to account for the development of myasthenia gravis in receptor immunized mice.
    Berman PW; Heinemann SF
    J Immunol; 1984 Feb; 132(2):711-7. PubMed ID: 6690616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to gallamine: an indicator of diminished neuromuscular function in experimental autoimmune myasthenia gravis.
    Hinman CL; Dambach GE; Hudson RA; Rauch HC
    J Neurosci Res; 1985; 14(2):271-8. PubMed ID: 4046075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C5 gene influences the development of murine myasthenia gravis.
    Christadoss P
    J Immunol; 1988 Apr; 140(8):2589-92. PubMed ID: 3356901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis.
    Huang D; Shi FD; Giscombe R; Zhou Y; Ljunggren HG; Lefvert AK
    Eur J Immunol; 2001 Jan; 31(1):225-32. PubMed ID: 11265638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenetics of experimental autoimmune myasthenia gravis.
    Christadoss P
    Crit Rev Immunol; 1989; 9(4):247-78. PubMed ID: 2679661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How the autoimmune response to acetylcholine receptor impairs neuromuscular transmission in myasthenia gravis and its animal model.
    Lindstrom J
    Fed Proc; 1978 Dec; 37(14):2828-30. PubMed ID: 214352
    [No Abstract]   [Full Text] [Related]  

  • 18. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to murine experimental autoallergic myasthenia gravis: the role of antibody specificity.
    Marzo AL; Garlepp MJ; Schon-Hegrad M; Dawkins RL
    Clin Exp Immunol; 1986 Apr; 64(1):101-6. PubMed ID: 3731522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis in two cats.
    Indrieri RJ; Creighton SR; Lambert EH; Lennon VA
    J Am Vet Med Assoc; 1983 Jan; 182(1):57-60. PubMed ID: 6822462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.